Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Technology Today News Acuitas Challenges Curevac In Legal Tussle Over Covid 19 Vaccine Technology is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology - Benzinga
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE CVAC, accusing it of failing to credit Acuitas on patents related to COVID-19 ... Read More
Acuitas sues CureVac for credit on COVID-19 vaccine patents
Canada-based Acuitas, which also developed related technology used in Pfizer and BioNTech's COVID-19 shots, asked the court to list its scientists as co-inventors on the CureVac patents, which ... Read More
Why Biopharmaceutical Player CureVac Shares Are Rising Today
Also Read: Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology All three of the dose levels tested were below those used in mRNA-based COVID-19 vaccines licensed in the U.S ... Read More
Curevac sues BioNTech over COVID-19 vaccine's mRNA technology
CureVac has been trying to develop its own COVID-19 vaccine and started a clinical trial for a second-generation vaccine candidate earlier this year in partnership with British company GSK. Read More
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a filing on Thursday in ... Read More
CureVac sues BioNTech, claiming Covid-19 vaccine infringes key mRNA patents - MedCity News
A Covid-19 vaccine based on the messenger RNA technology of CureVac has yet to successfully emerge from clinical trials, lagging well behind the mRNA shot from rival BioNTech that has landed ... Read More
CureVac Sues BioNTech Over COVID-19 Vaccine Patents
Pharma giant CureVac is suing Pfizer's vaccine partner BioNTech over the development of the COVID-19 vaccine.. CureVac has filed a lawsuit against their competitor, claiming patent violations in ... Read More
Moderna sues Pfizer and BioNTech over COVID-19 vaccine
The decades of development behind mRNA vaccine technology 02:32. Moderna and Pfizer's two-shot vaccines both use mRNA technology to help patients fight the coronavirus. Those vaccines work by ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus